SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-16-000543
Filing Date
2016-05-03
Accepted
2016-05-03 16:30:34
Documents
13
Period of Report
2016-05-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER DATED MAY 3, 2016 aurinia6kmpm160608.htm 6-K 6136
2 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS exhibit99-1.htm EX-99.1 6561
3 NOTICE AND ACCESS NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS exhibit99-2.htm EX-99.2 9560
4 INFORMATION CIRCULAR exhibit99-3.htm EX-99.3 467904
5 FORM OF PROXY exhibit99-4.htm EX-99.4 27066
6 aurinialogo.jpg GRAPHIC 3772
7 cpulogo.jpg GRAPHIC 10500
8 exhibit99-1p1x1x1.jpg GRAPHIC 10030
9 exhibit99-1p1x16x1.jpg GRAPHIC 43875
10 exhibit99-1p2x48x1.jpg GRAPHIC 4154
11 telephone.jpg GRAPHIC 12352
12 internet.jpg GRAPHIC 12013
13 qrcode.jpg GRAPHIC 12164
  Complete submission text file 0001176256-16-000543.txt   647486
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 161615862
SIC: 2834 Pharmaceutical Preparations